Decision to reintroduce aprotinin in cardiac surgery may put patients at risk

Cardiac surgery patients may be at risk because of the decision by Health Canada and the European Medicines Agency to reintroduce the use of aprotinin after its withdrawal from the worldwide market in 2007, assert the authors of a previous major trial that found a substantially increased risk…

Source:Decision to reintroduce aprotinin in cardiac surgery may put patients at risk